Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy

被引：6

作者：

Deguchi, Kentaro ^{[1
]}

Matsuzono, Kosuke ^{[1
]}

Nakano, Yumiko ^{[1
]}

Kono, Syoichiro ^{[1
]}

Sato, Kota ^{[1
]}

Deguchi, Shoko ^{[1
]}

Tanabe, Katsuyuki ^{[2
]}

Hishikawa, Nozomi ^{[1
]}

Ota, Yasuyuki ^{[1
]}

Yamashita, Toru ^{[1
]}

Ohta, Kiyoe ^{[3
]}

Motomura, Masakatsu ^{[4
,5
]}

Abe, Koji ^{[1
]}

机构：

[1] Okayama Univ, Grad Sch Med & Dent, Dept Neurol, Okayama, Japan

[2] Okayama Univ, Grad Sch Med & Dent, Dept Nephrol, Okayama, Japan

[3] Natl Hosp Org Utano Natl Hosp, Clin Res Ctr, Kyoto, Japan

[4] Nagasaki Univ Hosp, Dept Neurol & Strokol, Nagasaki, Japan

[5] Nagasaki Inst Appl Sci, Fac Engn, Dept Engn, Med Engn Course, Nagasaki, Japan

来源：

INTERNAL MEDICINE | 2018年 / 57卷 / 10期

关键词：

myasthenia gravis; periodic weekly blood purification therapy; anti-MuSK antibodies; TYROSINE KINASE MUSK; AUTOANTIBODIES; PLASMAPHERESIS; FEATURES; MG;

D O I：

10.2169/internalmedicine.9466-17

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 37-year-old man with anti-muscle-specific tyrosine kinase (MuSK) antibody-positive myasthenia gravis (MG) presented with subacute progressive dysphagia and muscle weakness of the neck and bilateral upper extremities. Conventional immune-suppressive treatments and high-dose intravenous immunoglobulin were ineffective. He then displayed repeated exacerbations and remissions over the course of two years, despite two to four sessions of plasma exchange (PE) every two months. The patient was successfully treated with outpatient periodic weekly blood purification therapy with alternative PE and double-filtration plasmapheresis using an internal shunt. This case report suggests the benefits of blood purification therapy with an internal shunt against anti-MuSK antibody-positive MG.

引用

页码：1455 / 1458

页数：4

共 22 条

[1] Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis [J].

Deymeer, F. ;

Gungor-Tuncer, O. ;

Yilmaz, V. ;

Parman, Y. ;

Serdaroglu, P. ;

Ozdemir, C. ;

Vincent, A. ;

Saruhan-Direskeneli, G. .

NEUROLOGY, 2007, 68 (08) :609-611

[2] Long-lasting treatment effect of rituximab in MuSK myasthenia [J].

Diaz-Manera, J. ;

Martinez-Hernandez, E. ;

Querol, L. ;

Klooster, R. ;

Rojas-Garcia, R. ;

Suarez-Calvet, X. ;

Munoz-Blanco, J. L. ;

Mazia, C. ;

Straasheijm, K. R. ;

Gallardo, E. ;

Juarez, C. ;

Verschuuren, J. J. ;

Illa, I. .

NEUROLOGY, 2012, 78 (03) :189-193

[3] Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis [J].

Evoli, A ;

Tonali, PA ;

Padua, L ;

Lo Monaco, M ;

Scuderi, F ;

Batocchi, AP ;

Marino, M ;

Bartoccioni, E .

BRAIN, 2003, 126 :2304-2311

[4] Response to therapy in myasthenia gravis with anti-MuSK antibodies [J].

Evoli, Amelia ;

Bianchi, Maria R. ;

Riso, Raffaella ;

Minicuci, Giacomo M. ;

Batocchi, Anna P. ;

Servidei, Serenella ;

Scuderi, Flavia ;

Bartoccioni, Emanuela .

MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE, 2008, 1132 :76-83

[5] Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies [J].

Hoch, W ;

McConville, J ;

Helms, S ;

Newsom-Davis, J ;

Melms, A ;

Vincent, A .

NATURE MEDICINE, 2001, 7 (03) :365-368

[6] Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice [J].

Klooster, Rinse ;

Plomp, Jaap J. ;

Huijbers, Maartje G. ;

Niks, Erik H. ;

Straasheijm, Kirsten R. ;

Detmers, Frank J. ;

Hermans, Pim W. ;

Sleijpen, Kevin ;

Verrips, Aad ;

Losen, Mario ;

Martinez-Martinez, Pilar ;

De Baets, Marc H. ;

van der Maarel, Silvere M. ;

Verschuuren, Jan J. .

BRAIN, 2012, 135 :1081-1101

[7] PLASMAPHERESIS IN REFRACTORY GENERALIZED MYASTHENIA-GRAVIS [J].

KORNFELD, P ;

AMBINDER, EP ;

MITTAG, T ;

BENDER, AN ;

PAPATESTAS, AE ;

GOLDBERG, J ;

GENKINS, G .

ARCHIVES OF NEUROLOGY, 1981, 38 (08) :478-481

[8] Creation of dialysis vascular access with normal flow increases brain natriuretic peptide levels [J].

Malik, Jan ;

Tuka, Vladimir ;

Krupickova, Zdislava ;

Chytilova, Eva ;

Holaj, Robert ;

Slavikova, Marcela .

INTERNATIONAL UROLOGY AND NEPHROLOGY, 2009, 41 (04) :997-1002

[9] Detection and characterization of MuSK antibodies in seronegative myasthenia gravis [J].

McConville, J ;

Farrugia, ME ;

Beeson, D ;

Kishore, U ;

Metcalfe, R ;

Newsom-Davis, J ;

Vincent, A .

ANNALS OF NEUROLOGY, 2004, 55 (04) :580-584

[10] Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis [J].

Nakata, R. ;

Motomura, M. ;

Masuda, T. ;

Shiraishi, H. ;

Tokuda, M. ;

Fukuda, T. ;

Ando, T. ;

Yoshimura, T. ;

Tsujihata, M. ;

Kawakami, A. .

EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (09) :1272-1276

← 1 2 3 →